You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 675 Safety and tolerability of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (RM-HNSCC)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
675 Safety and tolerability of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (RM-HNSCC)

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023328019
Dec 20239406
Jan 2024137018
Feb 2024122010
Mar 20247603
Apr 20247403
May 20247603
Jun 20247105
Jul 20246406
Aug 20246206
Sep 20245204
Oct 20246006
Nov 20245802
Dec 20249009
Jan 20257807
Feb 20251808
Mar 2025103
Apr 2025001
May 2025006
Jun 2025004
Total14610129